Alterity Therapeutics (ATHE) Non Operating Income (2014 - 2015)
Alterity Therapeutics (ATHE) posted quarterly Non Operating Income of $637791.5 for Q4 2015, down 10.62% year-over-year from $713578.3 in Q4 2014, and down 10.62% quarter-over-quarter from $713578.3 in Q4 2014.
Alterity Therapeutics (ATHE) Non Operating Income (2014 - 2015) Analysis & Trends
Alterity Therapeutics' Non Operating Income history runs 2 years deep, the most recent figure standing at $637791.5 for Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 637,791.54 |
| Dec 31, 2014 | 713,578.32 |